|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.67 USD | +1.86% |
|
+1.50% | +12.46% |
| Capitalization | 11.32B 15.25B 12.99B 12.02B 21.09B 1,418B 21.52B 141B 55.19B 681B 57.24B 56.02B 2,427B | P/E ratio 2026 * |
-15.8x | P/E ratio 2027 * | -15.6x |
|---|---|---|---|---|---|
| Enterprise value | 11.11B 14.97B 12.75B 11.8B 20.7B 1,392B 21.13B 138B 54.18B 669B 56.18B 54.99B 2,382B | EV / Sales 2026 * |
1,758x | EV / Sales 2027 * | 169x |
| Free-Float |
15.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Therapeutics Inc.
| 1 day | +1.86% | ||
| 1 week | +1.50% | ||
| Current month | +3.74% | ||
| 1 month | +27.23% | ||
| 3 months | +15.43% | ||
| 6 months | -7.87% | ||
| Current year | +12.46% |
| 1 week | 18.38 |  | 20.1 |
| 1 month | 15.25 | | 20.1 |
| Current year | 13.83 | | 20.2 |
| 1 year | 13.83 | | 36.91 |
| 3 years | 1.3 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 54 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
| Director/Board Member | 48 | 01/12/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 54 | 11/11/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -5.90% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.86% | +1.50% | -15.36% | +1,169.03% | 15.25B | |
| -0.59% | +4.53% | +28.56% | +93.99% | 49.79B | |
| +0.13% | +6.34% | +104.09% | +28.22% | 46.97B | |
| -3.00% | -4.69% | +125.77% | +831.47% | 33.42B | |
| +3.83% | +4.74% | -1.06% | -24.09% | 24.15B | |
| -1.89% | +0.11% | +66.13% | -34.60% | 18.97B | |
| -0.07% | +2.00% | +40.23% | -34.61% | 17.25B | |
| -0.72% | -0.07% | +58.02% | +194.85% | 16.25B | |
| -1.62% | -0.41% | +51.09% | - | 14.68B | |
| -0.89% | -4.99% | +63.84% | +115.13% | 11.92B | |
| Average | -0.28% | +0.90% | +52.13% | +259.93% | 24.86B | |
| Weighted average by Cap. | -0.34% | +2.05% | +58.94% | +232.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.32M 8.52M 7.26M 6.71M 11.78M 792M 12.02M 78.77M 30.82M 380M 31.96M 31.28M 1.36B | 66.57M 89.68M 76.4M 70.7M 124M 8.34B 127M 829M 325M 4.01B 337M 329M 14.27B |
| Net income | -719M -968M -825M -763M -1.34B -90.03B -1.37B -8.95B -3.5B -43.23B -3.63B -3.56B -154B | -755M -1.02B -867M -802M -1.41B -94.64B -1.44B -9.41B -3.68B -45.45B -3.82B -3.74B -162B |
| Net Debt | -208M -280M -239M -221M -387M -26.04B -395M -2.59B -1.01B -12.51B -1.05B -1.03B -44.56B | -98.6M -133M -113M -105M -184M -12.35B -187M -1.23B -481M -5.93B -498M -488M -21.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 19.67 $ | +1.86% | 2,521,285 |
| 09/04/26 | 19.31 $ | +2.66% | 1,868,282 |
| 08/04/26 | 18.81 $ | -2.13% | 2,088,786 |
| 07/04/26 | 19.22 $ | +2.84% | 1,503,554 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SMMT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition